Experienced in Heart Failure

Stephen G. Worthley

North Terrace, 
Adelaide, SA, AU 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Heart Failure
North Terrace, 
Adelaide, SA, AU 
OverviewLocationsClinical Research

Overview

Stephen Worthley practices in Adelaide, Australia. Mr. Worthley is rated as an Experienced expert by MediFind in the treatment of Heart Failure. His top areas of expertise are Aortic Regurgitation, Aortic Valve Stenosis, Hypertension, Transcatheter Aortic Valve Replacement (TAVR), and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 148 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Heart Failure.

Gender
Male

Locations

North Terrace, Adelaide, SA, Australia
Other Locations
Buildings 1&11, The Mill, 41-43 Bourke Road, Alexandria, NSW 2015, Australia
Level 6, North Terrace 5000, Adelaide, SA 5000, Australia
North Terrace, Adelaide, SA 5000, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

HighLife TSMVR Feasibility Study of the Open Cell CLARITY Valve in Patients With Moderate-severe or Severe MR, High Surgical Risk and With a High Risk for Left Ventricular Outflow Tract Obstruction (LVOTO)
HighLife TSMVR Feasibility Study of the Open Cell CLARITY Valve in Patients With Moderate-severe or Severe MR, High Surgical Risk and With a High Risk for Left Ventricular Outflow Tract Obstruction (LVOTO)
Enrollment Status: Recruiting
Publish Date: October 03, 2024
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Portico™ NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis
Evaluation of the Portico™ NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Device
Study Phase: Not Applicable
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
IntErnational Non-randomized, Single-arm, Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN
IntErnational Non-randomized, Single-arm, Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN
Enrollment Status: Terminated
Publish Date: May 27, 2021
Intervention Type: Device
Simultaneous Acquisition of Intravascular Ultrasound and Near Infrared Spectroscopy Data in the Coronary Artery Study
Simultaneous Acquisition of Intravascular Ultrasound and Near Infrared Spectroscopy Data in the Coronary Artery Study
Enrollment Status: Completed
Publish Date: December 14, 2020
Intervention Type: Device
Study Phase: Not Applicable
A Multicentre, Non-Randomised Controlled Study of the Safety, Performance, Quality of Life and Cost Effectiveness Outcomes of the Edwards SAPIEN XT™ Transcatheter Heart Valve in an Australian Population
A Multicentre, Non-Randomised Controlled Study of the Safety, Performance, Quality of Life and Cost Effectiveness Outcomes of the Edwards SAPIEN XT™ Transcatheter Heart Valve in an Australian Population
Enrollment Status: Completed
Publish Date: April 16, 2019
Intervention Type: Device
Study Phase: Not Applicable
First-In-Human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects With Treatment-Resistant Hypertension: A Safety and Feasibility Study
First-In-Human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects With Treatment-Resistant Hypertension: A Safety and Feasibility Study
Enrollment Status: Unknown
Publish Date: April 10, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

148 Total Publications

Thirty-Day And One-Year Outcomes Of Navitor Transcatheter Aortic Valve In Low- or Intermediate-Risk Patients.
Thirty-Day And One-Year Outcomes Of Navitor Transcatheter Aortic Valve In Low- or Intermediate-Risk Patients.
Journal: JACC. Cardiovascular interventions
Published: July 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Worthley's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile